Posted in | News | Uranium | Mining Business

Cameco: Production at Cigar Lake Mine Exceeds 10 Million Pounds of Uranium Concentrate

Cameco announced today that production from the Cigar Lake mine in northern Saskatchewan has surpassed 10 million pounds of uranium concentrate (Cameco's share 5 million pounds).

The Cigar Lake mine is owned by Cameco (50.025%), AREVA Resources Canada Inc. (37.1%), Idemitsu Canada Resources Ltd. (7.875%) and TEPCO Resources Inc. (5.0%) and is operated by Cameco.

Ore from the Cigar Lake mine is milled at the McClean Lake operation owned by AREVA (70%), Denison Mines Inc. (22.5%) and OURD Canada Co. Ltd. (7.5%) and operated by AREVA. Ore is transported 70 kilometres by truck from the Cigar Lake mine to the McClean Lake mill for processing into uranium concentrate.

The initial 2015 production target range for Cigar Lake was achieved during the third quarter. Cameco will report the full 2015 production for Cigar Lake in its fourth quarter results on February 5, 2016.

Profile
Cameco is one of the world's largest uranium producers, a significant supplier of conversion services and one of two Candu fuel manufacturers in Canada. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations. Our uranium products are used to generate clean electricity in nuclear power plants around the world. We also explore for uranium in the Americas, Australia and Asia. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan.

Qualified Person
The above scientific and technical information related to the Cigar Lake mining operation was approved by Les Yesnik, general manager, Cigar Lake, who is a qualified person for the purpose of National Instrument 43-101.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.